The infectious illness COVID-19 is at the basis of a global epidemic that has been going on for over two years. Novel coronavirus SARS-CoV-2, a virus that belongs to the same family as a common cold, causes the sickness. Potentially CBD might hinder the virus’ capacity to multiply in a host, which is now being investigated. Researchers haven’t yet been able to test for possible adverse effects, define suitable dose measurements, or determine the consistency of several experiments. SARS-CoV-2 symptoms can be prevented or minimised using CBD as a preventative strategy. Researchers have not yet recommended CBD as a therapy because of the lack of data on its long-term effectiveness, adverse effects, and dosage.